CompletedNot Applicable

Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement

Russia40 participantsStarted 2015-03-02

Plain-language summary

This study evaluates the safety and efficiency of surgical prevention of atrial fibrillation in patients with valvular heart disease and left atrium enlargement

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * rheumatic mitral valve lesion * the absence a history of AF * sinus rhythm * left atrium size more than 6.0 cm Exclusion Criteria: * refusal to participate in the study * aortic stenosis / regurgitation * coronary atherosclerosis

What they're measuring

composite outcome measure of complications

Timeframe: up to 1 year

Trial details

NCT IDNCT02474108

SponsorMeshalkin Research Institute of Pathology of Circulation

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2016-05-05

View on ClinicalTrials.gov More Atrial Fibrillation trials